AVIR - Atea Pharmaceuticals GAAP EPS of -$0.38 beats by $0.14 August, 08 2022 04:37 PM Atea Pharmaceuticals Inc. Atea Pharmaceuticals press release ( NASDAQ: AVIR ): Q2 GAAP EPS of -$0.38 beats by $0.14 . Cash and Cash Equivalents of $684.5 million at June 30, 2022 compared to $764.4 million at December 31, 2021 For further details see: Atea Pharmaceuticals GAAP EPS of -$0.38 beats by $0.14